Chang YH - Search Results

1

Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics.

Chen YT, Tsai CH, Chen CL, Yu JS, Chang YH. Chen YT, et al. Among authors: chang yh. J Food Drug Anal. 2019 Apr;27(2):387-403. doi: 10.1016/j.jfda.2018.09.005. Epub 2018 Oct 27. J Food Drug Anal. 2019. PMID: 30987711 Free PMC article. Review.

2

Systematic verification of bladder cancer-associated tissue protein biomarker candidates in clinical urine specimens.

Tsai CH, Chen YT, Chang YH, Hsueh C, Liu CY, Chang YS, Chen CL, Yu JS. Tsai CH, et al. Among authors: chang yh, chang ys. Oncotarget. 2018 Jul 20;9(56):30731-30747. doi: 10.18632/oncotarget.24578. eCollection 2018 Jul 20. Oncotarget. 2018. PMID: 30112103 Free PMC article.

3

Proteomic characterization of arsenic and cadmium exposure in bladder cells.

Chen YT, Ou Yang WT, Juang HH, Chen CL, Chen HW, Tsui KH, Chang YH, Tsai CH, Hsueh C, Liao WC. Chen YT, et al. Among authors: chang yh. Rapid Commun Mass Spectrom. 2020 Apr;34 Suppl 1:e8578. doi: 10.1002/rcm.8578. Epub 2020 Feb 8. Rapid Commun Mass Spectrom. 2020. PMID: 31499585

4

Development of a method for dansylation of metabolites using organic solvent-compatible buffer systems for amine/phenol submetabolome analysis.

Hsieh YJ, Chien KY, Chang CM, Hung CY, Li L, Chiang WF, Lee CC, Chang CH, Chang YH, Yu JS, Chen YT. Hsieh YJ, et al. Among authors: chang yh, chang cm, chang ch. Anal Chim Acta. 2022 Jan 2;1189:339218. doi: 10.1016/j.aca.2021.339218. Epub 2021 Oct 27. Anal Chim Acta. 2022. PMID: 34815039

5

Integration of the cancer cell secretome and transcriptome reveals potential noninvasive diagnostic markers for bladder cancer.

Chen YT, Tu WJ, Ye ZH, Wu CC, Ueng SH, Yu KJ, Chen CL, Peng PH, Yu JS, Chang YH. Chen YT, et al. Among authors: chang yh. Proteomics Clin Appl. 2024 Jan 9:e2300033. doi: 10.1002/prca.202300033. Online ahead of print. Proteomics Clin Appl. 2024. PMID: 38196148

6

TGF Beta1 Expression Correlates with Survival and Tumor Aggressiveness of Prostate Cancer.

Wu CT, Chang YH, Lin WY, Chen WC, Chen MF. Wu CT, et al. Among authors: chang yh. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1587-93. doi: 10.1245/s10434-015-4804-9. Epub 2015 Aug 14. Ann Surg Oncol. 2015. PMID: 26271396

7

The role of PD-L1 in the radiation response and clinical outcome for bladder cancer.

Wu CT, Chen WC, Chang YH, Lin WY, Chen MF. Wu CT, et al. Among authors: chang yh. Sci Rep. 2016 Jan 25;6:19740. doi: 10.1038/srep19740. Sci Rep. 2016. PMID: 26804478 Free PMC article.

8

Identifying cancer origin using circulating tumor cells.

Lu SH, Tsai WS, Chang YH, Chou TY, Pang ST, Lin PH, Tsai CM, Chang YC. Lu SH, et al. Among authors: chang yh, chang yc. Cancer Biol Ther. 2016 Apr 2;17(4):430-8. doi: 10.1080/15384047.2016.1141839. Cancer Biol Ther. 2016. PMID: 26828696 Free PMC article.

9

Lin KJ, Pang ST, Chang YH, Wu CT, Chuang KL, Chuang HC, Chuang CK. Lin KJ, et al. Among authors: chang yh. Chang Gung Med J. 2010 Mar-Apr;33(2):182-7. Chang Gung Med J. 2010. PMID: 20438671 Free article.

10

Thrombomodulin expression regulates tumorigenesis in bladder cancer.

Wu CT, Chang YH, Lin P, Chen WC, Chen MF. Wu CT, et al. Among authors: chang yh. BMC Cancer. 2014 May 28;14:375. doi: 10.1186/1471-2407-14-375. BMC Cancer. 2014. PMID: 24886404 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,631 results

Search Page